AbbVie (ABBV) Income from Non-Controlling Interests (2020 - 2026)

AbbVie (ABBV) has reported Income from Non-Controlling Interests for 7 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Income from Non-Controlling Interests fell 33.33% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $6.0 million (down 25.0% YoY), while the FY2025 annual figure was $7.0 million, down 12.5% from the prior year.
• Income from Non-Controlling Interests rose to $2.0 million in Q1 2026 per ABBV's latest filing, from -$1.0 million in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at $4.0 million in Q2 2022 and bottomed at -$1.0 million in Q4 2022.
• Historically, Income from Non-Controlling Interests has averaged $2.1 million across 5 years, with a median of $3.0 million in 2022.
• Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests plunged 200.0% — and 2023, when it soared 300.0%.
• AbbVie's Income from Non-Controlling Interests stood at -$1.0 million in 2022, then jumped by 300.0% to $2.0 million in 2023, then slumped by 150.0% to -$1.0 million in 2024, then changed by 0.0% to -$1.0 million in 2025, then jumped by 300.0% to $2.0 million in 2026.
• Business Quant data shows ABBV's Income from Non-Controlling Interests at $2.0 million in Q1 2026, -$1.0 million in Q4 2025, and $2.0 million in Q3 2025.